BridgeBio Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	392.59	414.62	393.95	356.08	363.77	436.09	92
Short-Term Investments	58.95	95.23	442.89	251.01	182.22	0	0
Cash & Cash Equivalents	451.54	509.85	836.84	607.09	545.99	436.09	92
Cash Growth	-11.44%	-39.07%	37.84%	11.19%	25.20%	374.03%	-
Receivables	1.75	17.08	19.75	0	2.85	0	0
Other Current Assets	24.31	21.92	32.27	35.73	19.78	9.14	5.14
Total Current Assets	477.59	548.85	888.86	642.82	568.62	445.22	97.13
Property, Plant & Equipment	19.84	25.25	45.97	36.83	5.63	1.58	0.44
Long-Term Investments	0	0	0	0	31.14	17.05	0
Goodwill and Intangibles	26.32	28.71	44.93	0	0	0	0
Other Long-Term Assets	22.63	20.22	33.03	23.93	26.29	1.09	0.47
Total Long-Term Assets	68.79	74.18	123.93	60.76	63.06	19.72	0.91
Total Assets	546.38	623.04	1,013	703.59	631.68	464.94	98.04
Accounts Payable	10.66	11.56	11.88	8.95	8.85	13.51	1.89
Deferred Revenue	6.1	8.16	0	0	0	0	0
Current Debt	4.13	3.68	4.94	5.25	0	0	0
Other Current Liabilities	122.97	98.04	118.25	81.45	51.53	19.07	6.67
Total Current Liabilities	143.84	121.43	135.07	95.65	60.39	32.58	8.55
Long-Term Debt	1,736	1,720	1,721	490.53	91.79	54.51	0
Other Long-Term Liabilities	9.36	26.64	22.07	9.52	3.53	0.5	0.31
Total Long-Term Liabilities	1,745	1,747	1,743	500.05	95.32	55	0.31
Total Liabilities	1,889	1,868	1,878	595.7	155.7	87.58	8.86
Total Debt	1,740	1,724	1,726	495.79	91.79	54.51	0
Debt Growth	0.94%	-0.15%	248.17%	440.13%	68.40%	-	-
Retained Earnings	-2,560.5	-1,918.15	-1,436.97	-888.76	-440.03	-179.44	-61.43
Comprehensive Income	0.03	-0.33	-0.13	0.19	0.25	0	0
Shareholders' Equity	-1,354.26	-1,254.62	-870.41	57.91	408.45	314.88	-61.43
Net Cash / Debt	-1,288.3	-1,213.71	-889.33	111.31	454.2	381.58	92
Net Cash / Debt Growth	-	-	-	-75.49%	19.03%	314.78%	-
Net Cash Per Share	-7.91	-8.23	-6.16	0.94	4.32	6.18	3.01
Working Capital	333.75	427.43	753.79	547.18	508.24	412.65	88.58
Book Value Per Share	-8.32	-8.51	-6.03	0.49	3.89	5.10	-2.01

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).